Increase of matrix metalloproteinase-2 in dialysate of rat sclerosing encapsulating peritonitis model

Nephrology

Volumn 7, Issue 4, 2002, Pages 161-169

  Hirahara, Ichiro ^a   Umeyama, Kazuhiro ^a   Shofuda, Ken Ichi ^a   Kusano, Eiji ^b   Masunaga, Yoshinori ^b   Honma, Sumiko ^b   Asano, Yasushi ^b  

^a TERUMO CORPORATION   (Japan)

^b JICHI MEDICAL UNIVERSITY   (Japan)

Author keywords

Continuous ambulatory peritoneal dialysis; Matrix metalloproteinase 2; Sclerosing encapsulating peritonitis

Indexed keywords

CHLORHEXIDINE GLUCONATE; GELATIN; GELATINASE A; GELATINASE B; INTERSTITIAL COLLAGENASE; TISSUE INHIBITOR OF METALLOPROTEINASE 2;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL INFILTRATION; CONTROLLED STUDY; DIALYSATE; DISEASE COURSE; ENZYME SYNTHESIS; GENE EXPRESSION; GLUCOSE ABSORPTION; IMMUNOHISTOCHEMISTRY; MALE; NONHUMAN; PERITONEUM ADHESION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SCLEROSING ENCAPSULATING PERITONITIS; SCLEROSING PERITONITIS; THICKNESS; ZYMOGRAPHY;

EID: 0036047277     PISSN: 13205358     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1797.2002.00100.x     Document Type: Article

References (32)

1. Sclerotic thickening of the peritoneal membrane in maintenance peritoneal dialysis patients
2. Progressive sclerosing peritonitis: A late and severe complication of maintenance peritoneal dialysis
3. Pathogenesis of peritoneal Fibrosing Syndromes (Sclerosing Peritonitis) in Peritoneal Dialysis
4. Loss of ultrafiltration and sclerosing encapsulating peritonitis during CAPD evaluation of the potential risk factors
5. Sclerosing encapsulating peritonitis in patients undergoing continuous ambulatory peritoneal dialysis: A report of the Japanese Sclerosing Encapsulating Peritonitis Study Group
6. Peritoneal reactions to particulate matter in peritoneal dialysis solutions
7. Peritonitis
8. In vitro biocompatibility of bicarbonate-based peritoneal dialysis solutions
9. Sclerosing peritonitis - The contribution of chlorhexidine in alcohol
10. Sclerosing encapsulating peritonitis in rats induced by long-term intraperitoneal administration of antiseptics
11. Sclerosing peritonitis complicating prolonged use of chlorhexidine in alcohol in the connection procedure for continuous ambulatory peritoneal dialysis
12. A case of a dialysis patient with sclerosing peritonitis successfully treated with corticosteroid therapy alone
13. Sclerosing encapsulating peritonitis associated with continuous ambulatory peritoneal dialysis: Surgical management
14. Abdominal cocoon in a man: Preoperative diagnosis and literature review
15. Ultrasound changes in sclerosing peritonitis following continuous ambulatory peritoneal dialysis
16. H-ras oncogene-transformed human bronchial epithelial cells (TBE-1) secrete a single metalloprotease capable of degrading basement membrane collagen
17. Differential expression of extracellular matrix remodeling genes in a murine model of bleomycin-induced pulmonary fibrosis
18. Localization of matrix metalloproteinases-1, -2, and -9 and tissue inhibitor of metalloproteinase-2 in interstitial lung diseases
19. Molecular bases of the acute coronary syndromes
20. Matrix degradation in renal disease
21. Altered balance between matrix metalloproteinases and their inhibitors in experimental biliary fibrosis
22. Dual expression of matrix metalloproteinase-2 and membrane-type 1-matrix metalloproteinase in fibrotic human livers
23. Fibrinogen or its derivatives in the Kurloff cells
24. Histochemical studies of glycosaminoglycans in developing periodontal ligaments of ICR mice
25. Peritoneal equilibration test
26. Expression of three membrane-type matrix metalloproteinases (MT-MMPs) in rat vascular smooth muscle cells and characterization of MT3-MMPs with and without transmembrane domain
27. Hyperosmolality suppresses but TGF beta 1 increases MMP9 in human peritoneal mesothelial cells
28. Elevated expression of membrane-type 1 and 3 matrix metalloproteinases in rat vascular smooth muscle cells activated by arterial injury
29. Mechanism of cell surface activation of 72-kDa type IV collagenase. Isolation of the activated form of the membrane metalloprotease
30. Cell surface activation of progelatinase A (proMMP-2) and cell migration
31. Production and regulation of matrix metalloproteinases and their inhibitors by human peritoneal mesothelial cells
32. Peritonitis increases MMP-9 activity in peritoneal effluent from CAPD patients